Thursday, May 8, 2014

Terme Bancorp, Inc. (TMEB) Consumer-Focused Money Services Firm Takes On Medical Marijuana, Device, and Therapy Markets

Terme Bancorp, a holding company focused on the booming global electronic money services space, as well as the relevant associated behavioral dynamics among consumers, operates through a growing family of wholly owned subsidiaries, each with a distinct target market. Beyond the company’s Terme Capital, Inc. subsidiary, whose foundations stretch back to the company’s 1987 acquisition/operation of Argo Federal Savings and Loan Association from FSLIC, as well the purchase in 1995 of OnLine Financial Services (thus establishing one of the very first internet branch operations on earth), there is the Terme Mortgage, Inc. subsidiary, an established mortgage services operation.

The company has a solid track record of achievements under its belt and the feat of establishing a successful branch on the West Side of Chicago (where there hadn’t been one in 35 years), as well as the successful deployment of ATMs throughout the inner city, really reinforces TMEB’s philanthropic commitment to serving populations like the unbanked and under-banked, in this case with comprehensive financial services. The company used their muscle and ingenuity, taking point on the mission to foster an electronic debit card framework for the area and the results were superb, with government assistance payment streamlining and leveraging of a social services agency, to bring much needed jobs to ex-offenders and the like, helping to simultaneously offset the ongoing housing crisis for the local market.

This same dauntless, charitable attitude by TMEB has led to the formation of a new wholly owned subsidiary, Terme Medical Ventures, Inc., which will be tasked with hammering out quality investments in a variety of consumer-oriented medical vectors. The three primary initial targets for this new subsidiary will be the lucrative and rapidly expanding medical marijuana market, as well as the clinical device and infectious disease treatment markets. Terme Medical Ventures will emphasize refining an ability to provide the best in cutting-edge growing and distribution technologies, as well as related services, in addition to aligning key affinity relationships and partnerships in what is now a rapidly burgeoning industry.

Nationally speaking, the legal market for the broadest category of marijuana sales was around $1.53B in 2013, a figure expected to climb 422% to a whopping $8B by 2018 alone (with the ArcView report placing the figure substantially higher at $10.2B). Company plans to do some serious damage in the thriving device space will be bolstered by important relationships that management has already established in the space. TMEB will be fast out of the gate developing or licensing clinical device technology that will let users not only do over watch on their own health with robust monitoring, but also improve their health at the same time. Infectious disease is a good third leg here and the overlap should be apparent to anyone following the sector closely.

The prevailing marijuana legislation basically says it all, with cancer, glaucoma, and HIV/AIDS at the top of the list for conditions associated with legal permitting in Colorado for instance. Major secondaries in muscle spasm, seizure, severe pain, severe nausea, and even severe weight loss/muscle atrophy (cachexia), merely cement the longer-term upside for infectious disease applications. The Charlotte’s Web strain used by the parents of Charlotte Figi to treat her epileptic seizures has really galvanized this nascent industry and it is quiet easy to see the vast potential for therapeutic applications across the broader market, especially when executed in conjunction with the right kinds of health monitoring technologies.

For more info on Terme Bancorp, Inc., visit www.TermeBancorp.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net


Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: